Global Live Cell Imaging Market - Segmented by Product, by Technology, by Application and Geography - Growth, Trends, and Forecast (2022 - 2030)
The Live Cell Imaging market is expected to register a growth rate of nearly 8.5% over the forecast period, 2018 to 2023. Live cell imaging techniques allows the real-time examination of every aspect of cellular function under normal and experimental examinations. As per the geographical analysis, the North American region possess several factors such as well-developed healthcare infrastructure, high content screening techniques in drug discovery and government funding in cell based research which makes this market to retain dominance in this region.
Rising Prevalence of Chronic Disease Demanding Higher & Quicker Diagnostic Facilities Boost the Growth of Live Cell Imaging Market
According to the World Health Organization (WHO), chronic disease are expected to increase by 57% by the year 2020. Increased demand on healthcare systems due to the chronic disease has become a major concern. Also, the rise of age and lifestyle-related chronic disease is increasing healthcare demand and spending. In developing market, cancer and heart disease are becoming the main causes of death, the result of urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. As per WHO, China and India now have the world’s highest number of diabetes sufferers at more than 98 million and 65 million individuals. Due to increasing prevalence of chronic disease there is a high demand of medical devices that enable early detection and quick diagnosis that could prove to be particularly impactful. Others factors that are spurring the growth of the market are adoption of high-content screening techniques in drug discovery and government funding for cell-based research.
High Cost of High-Content Screening Systems Restrain Growth of the Live Cell Imaging Market
High-content screening (HCS) is a well-established approach for the multi-parametric analysis of cellular events. HCS imaging systems have continually evolved with improvements that enabled to meet user demands of greater flexibility and the growing requirements of assays involving complex cellular disease models. However, high cost of HCS is acting as a major restraint as high-throughput, cell-based screening using such microtiter-plate platforms which are very expensive because of the relatively large amounts of high-cost reagents and cells are needed, particularly when 96-well plates are used. Moreover, the technology requires highly skilled professional in order to study and understand the cell functions. The lack of availability of skilled professional is also expected to restrain the growth of live cell imaging market.
North America holds the largest share in the Live Cell Imaging Market
North America dominated the market share in 2017, due to generous investements and funding avilable for research in this field which is the key driver in this region. Also, in 2016 the Government of Canada has announced the funding to support Canada Research Chairs Program. This fund was a part of total funding worth more than USD 164 million that was allocated for infrastructure and also projects on cell imaging in plant development, that are untaken by the McGill University are also included in this program.
Key Developments in the Live Cell Imaging Market
• Mar 2018: Nikon Corporation has released a new product new N-SIM S Super Resolution Microscope which enables super-solution imaging of live cells at ten times greater than the speed of conventional structured illumination microscopy (SIM).
Major Players: BECTON, DICKINSON AND COMPANY, CARL ZEISS, GE HEALTHCARE, LEICA MICROSYSTEMS, OLYMPUS CORPORATION, MOLECULAR DEVICES, LCC, NIKON CORPORATION, PERKINELMER, INC., SIGMA-ALDRICH CORPORATION, and THERMO FISHER SCIENTIFIC, INC. among others.
Reasons to Purchase Live Cell Imaging Market Report
• Current and future of Live Cell Imaging market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of Live Cell Imaging Market Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
Rising Prevalence of Chronic Disease Demanding Higher & Quicker Diagnostic Facilities Boost the Growth of Live Cell Imaging Market
According to the World Health Organization (WHO), chronic disease are expected to increase by 57% by the year 2020. Increased demand on healthcare systems due to the chronic disease has become a major concern. Also, the rise of age and lifestyle-related chronic disease is increasing healthcare demand and spending. In developing market, cancer and heart disease are becoming the main causes of death, the result of urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. As per WHO, China and India now have the world’s highest number of diabetes sufferers at more than 98 million and 65 million individuals. Due to increasing prevalence of chronic disease there is a high demand of medical devices that enable early detection and quick diagnosis that could prove to be particularly impactful. Others factors that are spurring the growth of the market are adoption of high-content screening techniques in drug discovery and government funding for cell-based research.
High Cost of High-Content Screening Systems Restrain Growth of the Live Cell Imaging Market
High-content screening (HCS) is a well-established approach for the multi-parametric analysis of cellular events. HCS imaging systems have continually evolved with improvements that enabled to meet user demands of greater flexibility and the growing requirements of assays involving complex cellular disease models. However, high cost of HCS is acting as a major restraint as high-throughput, cell-based screening using such microtiter-plate platforms which are very expensive because of the relatively large amounts of high-cost reagents and cells are needed, particularly when 96-well plates are used. Moreover, the technology requires highly skilled professional in order to study and understand the cell functions. The lack of availability of skilled professional is also expected to restrain the growth of live cell imaging market.
North America holds the largest share in the Live Cell Imaging Market
North America dominated the market share in 2017, due to generous investements and funding avilable for research in this field which is the key driver in this region. Also, in 2016 the Government of Canada has announced the funding to support Canada Research Chairs Program. This fund was a part of total funding worth more than USD 164 million that was allocated for infrastructure and also projects on cell imaging in plant development, that are untaken by the McGill University are also included in this program.
Key Developments in the Live Cell Imaging Market
• Mar 2018: Nikon Corporation has released a new product new N-SIM S Super Resolution Microscope which enables super-solution imaging of live cells at ten times greater than the speed of conventional structured illumination microscopy (SIM).
Major Players: BECTON, DICKINSON AND COMPANY, CARL ZEISS, GE HEALTHCARE, LEICA MICROSYSTEMS, OLYMPUS CORPORATION, MOLECULAR DEVICES, LCC, NIKON CORPORATION, PERKINELMER, INC., SIGMA-ALDRICH CORPORATION, and THERMO FISHER SCIENTIFIC, INC. among others.
Reasons to Purchase Live Cell Imaging Market Report
• Current and future of Live Cell Imaging market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of Live Cell Imaging Market Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
